Thermo Fisher Scientific Inc. (TMO)

NYSE: TMO · Real-Time Price · USD

694.76

+17.82 (2.63%)

At close: Nov 6, 2026, 4:00 PM EST

705.00

+10.24 (1.47%)

Pre-market: Nov 9, 2026, 8:54 AM EST

Thermo Fisher Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	257,420	217,704	198,988	205,083	216,998	262,925
Market Cap Growth	20.70%	9.41%	-2.97%	-5.49%	-17.47%	42.43%
Enterprise Value	292,729	249,974	227,963	234,504	243,417	272,609
Last Close Price	694.76	577.86	516.97	526.03	544.30	658.04

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	36.62	32.47	31.41	34.21	31.22	34.04
Forward PE	25.80	24.05	22.87	24.65	25.00	32.55
PS Ratio	5.44	4.89	4.64	4.79	4.83	6.71
PB Ratio	4.70	4.07	4.01	4.38	4.92	6.42
P/FCF Ratio	33.89	34.60	27.38	29.61	31.40	38.73
P/OCF Ratio	27.61	27.85	22.96	24.40	23.71	28.24
PEG Ratio	2.61	3.13	2.76	2.51	1.17	1.91

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	6.18	5.61	5.32	5.47	5.42	6.95
EV/EBITDA Ratio	24.13	22.44	21.04	21.86	20.39	21.03
EV/EBIT Ratio	32.43	29.91	29.50	32.03	28.44	26.28
EV/FCF Ratio	38.54	39.72	31.37	33.85	35.22	40.15

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.75	0.76	0.66	0.78	0.82	0.89
Debt / EBITDA Ratio	3.28	3.51	2.90	3.28	2.92	2.74
Debt / FCF Ratio	5.45	6.49	4.51	5.30	5.23	5.35
Net Debt / Equity Ratio	0.64	0.57	0.55	0.61	0.63	0.78
Net Debt / EBITDA Ratio	2.91	2.76	2.51	2.67	2.31	2.46
Net Debt / FCF Ratio	4.65	4.89	3.74	4.13	4.00	4.69
Asset Turnover	0.44	0.43	0.44	0.44	0.47	0.48
Inventory Turnover	4.89	5.05	4.99	4.81	4.86	4.31
Quick Ratio	1.23	1.36	1.14	1.27	1.06	1.00
Current Ratio	1.81	1.89	1.66	1.76	1.48	1.50
Return on Equity (ROE)	13.38%	13.02%	13.13%	13.09%	16.35%	20.47%
Return on Assets (ROA)	5.19%	5.03%	4.93%	4.67%	5.56%	7.90%
Return on Invested Capital (ROIC)	9.00%	9.59%	9.19%	9.49%	10.75%	15.17%
Return on Capital Employed (ROCE)	9.00%	8.80%	9.20%	8.60%	10.70%	12.70%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	2.73%	3.08%	3.18%	2.92%	3.20%	2.94%
FCF Yield	2.95%	2.89%	3.65%	3.38%	3.19%	2.58%
Dividend Yield	0.27%	0.30%	0.30%	0.26%	0.22%	0.16%
Payout Ratio	9.91%	9.49%	9.20%	8.72%	6.55%	5.11%
Buyback Yield / Dilution	1.91%	1.31%	1.29%	1.52%	0.76%	0.50%
Total Shareholder Return	2.18%	1.60%	1.59%	1.79%	0.97%	0.66%

SEC Filings: 10-K · 10-Q